Lonza sells lipid oral dosage facilities to NextPharma in softgel market exit

Related Articles

FormattedPicture

NUTRITION & HEALTH NEWS

While sports nutrition maintains its hold in the nutrition realm, industry experts are adamant that opportunities have not diminished. NutritionInsight speaks to... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

US-based Healthycell has landed US$1.57 million in bridge round funding, led by Keen Growth Capital and with participation from the Balanced Breakfast Fund. The... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

Regulatory demands and product transparency will change the nutraceutical industry in the coming years. Additionally, the COVID-19 pandemic has exposed the fragility of... Read More

FormattedPicture

BUSINESS NEWS

Catalent is addressing the rising demand for alternative delivery formats with the US$1 billion acquisition of Bettera Brands, which offers nutritional gummies, softgels... Read More

FormattedPicture

NUTRITION & HEALTH NEWS

The joint health market is experiencing a rapid recovery as COVID-19 lockdown measures continue to ease. In light of this, Lonza is highlighting the importance of... Read More

trans